• 53
  • 10
  • 收藏

Analysts Adjust Palantir Price Targets Post Q3 Results

Benzinga2021-11-11

  • Few analysts slashed price targets onPalantir Technologies Inc(NYSE:PLTR)despite the Q3 beat.

  • RBC Capitalanalyst Rishi Jaluria downgraded toUnderperform from Sector Performwith a price target of $19, down from $25, implying a 17% downside.

  • The analyst cites the company's "mixed" Q3 results with deceleration in the government business while noting that its commercial acceleration that is being fueled by SPAC investments is "unsustainable."

  • Jaluria adds that his confidence in Palantr's 30% growth is reduced, and he sees the stock's valuation as "full."

  • William Blair analyst Kamil Mielczarek says Palantir revenues decelerated in the quarter to 36% year-over-year, down from 49% in the first half of 2021.

  • While Palantir delivered "strong" headline numbers, the growth in the second half of 2021 is "heavily reliant on strategic investments."

  • The analyst remains concerned about the business's ability to maintain 30% organic growth over the near term and keeps an Underperform rating on Palantir.

  • Citi analyst Tyler Radke states Palantir's decelerating growth "came into center view" in Q3 with weakness in both commercial and government.

  • While guidance for Q4 was issued slightly ahead of the Street, it still implies slower growth, even on an easier comparison and with significant tailwinds from SPAC-related customer contracting.

  • He reiterates a Sell rating on the shares with an $18 price target.

  • Wolfe Research analyst Alex Zukin lowered the price target to $20 from $25, and maintained a Peer Perform following what he calls an "interesting" Q3 report.

  • He notes that shares were down after the announcement, which he blames a "meaningful top-line deceleration," pointing out that total revenues, ex. SPAC-contributions of $373 million grew 29% year-over-year, which Zukin said is up only less than $1 million sequentially from Q2.

  • His lower price target is due to the core growth deceleration as he is "not yet comfortable assigning a similar confidence interval and multiple to SPAC-based commercial revenue."

  • Morgan Stanley analyst Keith Weiss raised the price target to $24 from $22, implying a 4% upside.

  • He reiterated an Underweight after delivering another beat versus consensus expectations "across all key headline metrics" in Q3.

  • Weiss sees "signs of slowing underneath the hood" as a slowdown in core revenue and commercial growth, coupled with a sharper slowdown in the government segment, which opens up the debate on the durability of Palantir's growth.

  • Price Action:PLTR shares traded lower by 5.6% at $22.9 on the last check Wednesday.

免责声明:本文观点仅代表作者个人观点,不构成本平台的投资建议,本平台不对文章信息准确性、完整性和及时性做出任何保证,亦不对因使用或信赖文章信息引发的任何损失承担责任。

举报

评论10

  • HoSei
    ·2021-11-12
    It is still a great buy for me at $22-24
    回复
    举报
  • ckcy
    ·2021-11-11
    Keeping. 
    回复
    举报
  • DiamondHandS
    ·2021-11-11
    Don't listen to the FUD!!
    回复
    举报
  • KelW87
    ·2021-11-11
    I hope palantir goes up up up
    回复
    举报
  • Wnnn
    ·2021-11-11
    Tell me your opinion about this news...
    回复
    举报
  • 6bd41974
    ·2021-11-11
    J
    回复
    举报
    收起
  • HOZZ
    ·2021-11-11
    Haha they push the price down then they scoop up the shares at cheap 😅😅 so common
    回复
    举报
  • ChrisLiew
    ·2021-11-11
    Like and comment pls
    回复
    举报
    收起
    • T0000024852
      Hi
      2021-11-11
      回复
      举报
    • aozora
      Done
      2021-11-11
      回复
      举报
  • SiewLooiWan
    ·2021-11-11
    Sure
    回复
    举报
    收起
    • 6bd41974
      K
      2021-11-11
      回复
      举报
    • ChrisLiew
      [强]
      2021-11-11
      回复
      举报
  • Never ever f
    ·2021-11-11
    Great 👍🏻 
    回复
    举报
 
 
 
 

热议股票

 
 
 
 
 

7x24